InterCure Ltd. — Form 6-K Summary
Reporting period: Month ended October 31, 2023. Filed October 31, 2023, under Commission File No. 001-40614. InterCure is an Israeli foreign private issuer that files annual reports on Form 20-F.
Business Context
The filing is a Form 6-K cover submission identifying an exhibit described as a press release dated October 31, 2023. The provided filing text does not include the contents of that press release or provide operating or financial results.
Financial and Operating Metrics
The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, guidance, or other key financial metrics.
Material Changes Versus Prior Period
No material period-over-period changes are described in the provided text.
Outlook, Risks, and Unusual Items
No management outlook, risk factors, contingencies, or unusual items are described. The referenced October 31, 2023 press release may contain additional information, but its contents are not included in the source text.
Key Facts to Verify
- Obtain and review Exhibit 99.1, the October 31, 2023 press release.
- Verify whether the referenced press release contains financial results, operating updates, guidance, or material corporate developments.
- Confirm any reported metrics against InterCure’s subsequent Form 20-F or other SEC filings.